A Closer Look at Specific Therapeutic Strategies in Leukemia

References

• Veer, L. and Jong, D. (2002) "The microarray way to tailored cancer treatment", Nature Med., 8, 13–14.
   Google Scholar
• Farderl, S., Kantarjian, H., Talpaz, M. and Estrov, Z. (1998) "Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia", Blood, 91, 3995–4019.
   Google Scholar
• Shet, A., Jahagirdar, B. and Verfaillie, C. (2002) "Chronic myelogenous leukemia: mechanisms underlying disease progres-sion", Leukemia, 16, 1402 — 1411.
   Google Scholar
• Haferlach, T., Kohlmann, A., Kern, W., Hiddemann, W., Schnitt-ger S. and Schoch, C. (2003) "Gene expression profiling as a tool for the diagnosis of acute leukemias", Semin. HematoL, 40, 281–295.
   Google Scholar
• Look, A. (1997) "Oncogenic transcription factors in the human acute leukemias", Science, 278, 1059–1064.
   Google Scholar
• Rabbitts, T. and Stocks, M. (2003) "Chromosomal translocation products engender new intracellular therapeutic technologic", Nature Med., 9, 383–386.
   Google Scholar
• Lee, S. and Schmitt, C. (2003) "Chemotherapy response and resistance", Curr. Opin. Genet. Develop., 13, 90–96.
   Google Scholar
• Speck, N., Stacy, T., Wang, Q., et al. (1999) "Core-binding factor: a central player in hematopoiesis and leukemia", Cancer Res., 59, 1789 — 1793.
   Google Scholar
• Rowley, J., Golomb, H. and Dougherty, C. (1977) "15/17 translocation a consistent chromosomal change in acute promyelo-cytic", Lancet, 1, 549–550.
   Google Scholar
• de The, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990) "The t(15;17) translocations of acute promyelocytic leukae-mia fases the retinoic acid receptor alpha gene to a novel transcribed locus", Nature, 347, 558–561.
   Google Scholar
• Collins, S. (2002) "The role of retinoids and retinoic acid receptors in normal hematopoiesis", Leukemia, 16, 1896— 1905.
   Google Scholar
• Kakizuka, A., Miller, W., Umesono, K., et al. (1991) "Chromoso-mal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor", Cell, 66, 663–674.
   Google Scholar
• Kastner, P., Perez, A., Lutz, Y., et al. (1992) "Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins", Embo J., 11, 629–642.
   Google Scholar
• Pandolfi, P., Alcalay, M., Longo, L., et al. (1992) "Molecular genetics of the t(15;17) of acute promyelocytic leukemia (APL)", Leukemia, 6\(Suppl 3), 120S —122S.
   Google Scholar
• Zelent, A., Guidez, F., Melnick, A., Waxman, S. and Licht, J. (2001) "Translocations of the RARalpha gene in acute promyelocytic leukemia", Oncogene, 20, 7186–7203.
   Google Scholar
• Melnick, A. and Licht, J. (1999) "Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia", Blood, 93, 3167–3215.
   Google Scholar
• Huang, M., Ye, Y., Chen, S., et al. (1988) "Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia", Blood, 72, 567 — 572.
   Google Scholar
• Lin, R., Nagy, L., Inoue, S., et al. (1998) "Role of the histone deacetylase complex in acute promyelocytic leukaemia", Nature, 391, 811–814.
   Google Scholar
• Grignani, F., De Matteis, S., Nervi, C., et al. (1998) "Fusion proteins of the retinoic acid receptor-a recruit histone deacetylase in promyelocytic leukaemia", Nature, 319, 815–818.
   Google Scholar
• Guidez, F., Huang, W., Tong, J., etal. (1994) "Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RARalpha patient", Leukemia, 8, 312–317.
   Google Scholar
• Chen, Z., Guidez, F., Rousselot, P., et al. (1994) "PLZF-RARalpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors", Proc. Nat. Acad. Sci. USA, 91, 1178–1182.
   Google Scholar
• Licht, J., Shaknovitch, R., English, M., et al. (1996) "Reduced and alterated DNA-binding and transcriptional properties of the PLZP-retinoic acid receptor-a chimera generated in t(11;17)-associated acute promyelocytic leukemia", Oncogene, 12, 323–336.
   Google Scholar
• Licht, J., Chomienne, C., Goy, A., et al. (1995) "Clinical and molecular characterization of a rare syndrome of acute promyelo-cytic leukemia associated with translocation (11;17)", Blood, 85, 1083–1094.
   Google Scholar
• He, L.-Z., Guidez, F., Tribioli, C., et al. (1998) "Distinct interactions of PML-RARa and PLZF-RARa with co-repressors determine differential responses to RA in APL", Nature Genet., 18, 126— 135.
   Google Scholar
• Guidez, F., Ivins, S., Zhu, J., Soderstrom, M., Waxman, S. and Zelent, A. (1998) "Reduced retinoic acid-sensitivities of nuclear receptor co-repressor binding to PML-and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelo-cytic leukemia", Blood, 91, 2634–2642.
   Google Scholar
• Mu, Z., Chin, K., Liu, J., Lozano, G. and Chang, K. (1994) "PML, a growth suppressor disrupted in acute promyelocytic leukemia", Mol. Cell Biol., 14, 6858–6867.
   Google Scholar
• Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., et al. (2000) "The function of PML in p53-dependent apoptosis", Nat. Cell Biol., 2, 730–736.
   Google Scholar
• Salomoni, P. and Pandolfi, P. (2002) "The role of PML in tumor suppression", Cell, 108, 165–170.
   Google Scholar
• Shaknovich, R., Yeyati, P., Ivins, S., et al. (1998) "The promyelo-cytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis", Mol. Cell Biol., 18, 5533 — 5545.
   Google Scholar
• Tallman, M., Andersen, J., Schiffer, C., et al. (1997) "All-trans-retinoic acid in acute promyelocytic leukemia", N. Engl. J. Med., 337, 1021–1028.
   Google Scholar
• Imaizumi, M., Suzuki, H., Yoshinari, M., et al. (1998) "Mutations in the E-domain of RARa portion of the PML/RARa chimeric gen may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia", Blood, 92, 374–382.
   Google Scholar
• Miller, W. and Waxman, S. (2002) "Differentiation induction as treatment for hematologic malignancies", Oncogene, 21, 3496 — 3506.
   Google Scholar
• Cote, S., Rosenauer, A., Bianchini, A., et al. (2002) "Response to histone deacetylase inhibition of novel PML/RARa mutants detected in retinoic acid-resistant APL cells", Blood, 100, 2586 — 2596.
   Google Scholar
• Batova, A., Shao, L., Diccianni, M., et al. (2002) "The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines", Blood, 100, 3319 — 3324.
   Google Scholar
• Jing, Y., Xia, L. and Waxman, S. (2002) "Targeted removal of PML-RARa protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia", Blood, 100, 1008 — 1013.
   Google Scholar
• Lutterbach, B., Westendolf, J., Linggi, B., et al. (1998) "ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors", Mol. Cell Biol., 18, 7176–7184.
   Google Scholar
• Ferrera, F., Fazi, F., Bianchimi, A., et al. (2001) "Histone deacetylase-targeted treatment restores retinoic acid signalling and differentiation in acute myeloid leukemia", Cancer Res., 61, 2–7.
   Google Scholar
• Redner, R., Wang, J. and Liu, J. (1999) "Chromatin remodeling and leukemia: new therapeutic paradigms", Blood, 94, 417–428.
   Google Scholar
• Platanias, L. (2003) "Map kinase signaling pathways and hemato-logic malignancies", Blood, 101, 4667 —4679.
   Google Scholar
• Faderl, S., Talpaz, M., Estrov, Z. and Kantarjian, H. (1999) "Chronic myelogenous leukemia: biology and therapy", Ann. Intern. Med., 131, 207–219.
   Google Scholar
• Sawyers, C. (1999) "Chronic myeloid leukemia", N. Engl. J. Med., 340, 1330–1340.
   Google Scholar
• Deininger, M., Goldman, J. and Melo, J. (2000) "The molecular biology of chronic myeloid leukemia", Blood, 96, 3343— 3356.
   Google Scholar
• Goldman, J. and Druker, B. (2001) "Chronic myeloid leukemia: current treatment options", Blood, 98, 2039 — 2042.
   Google Scholar
• Druker, B., Tamura, S., Buchdunger, E., et al. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nature Med., 2, 561–566.
   Google Scholar
• le Coutre, P., Mologni, L., Cleris, L., et al. (1999) "In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor", J. Nat. Cancer Inst., 91, 163–168.
   Google Scholar
• Druker, B., Talpaz, M., Resta, D., et al. (2001) "Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia", N. Engl. J. Med., 344, 1031–1037.
   Google Scholar
• Ottmann, 0., Druker, B., Sawyers, C., et al. (2002) "A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias", Blood, 100, 1965–1971.
   Google Scholar
• Sawyers, C., Hochhaus, A., Feldman, E., et al. (2002) "Imatinib induces hematologic and cytogenetic response in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study", Blood, 99, 3530–3539.
   Google Scholar
• Talpaz, M., Silver, R., Druker, B., et al. (2002) "Imatinib induces durable hematologic and cytogenetic response in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study", Blood, 99, 1928 — 1937.
   Google Scholar
• Hoover, R., Mahon, F., Melo, J. and Daley, G. (2002) "Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336", Blood, 100, 1068–1071.
   Google Scholar
• Kuroda, J., Kimura, S., Segawa, H., et al. (2003) "The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph + leukemia activity of imatinib mesylate", Blood, 102, 2229 — 2235.
   Google Scholar
• Yu, C., Rahmani, M., Conrad, D., Subler, M., Dent, P. and Grant, S. (2003) "The proteasome inhibitor bortezomib interacts synergis-tically with histone deacetylase inhibitors to induce apoptosis in Bcr-Abl + cells sensitive and resistant to STI571", Blood, 102, 3765 — 3774.
   Google Scholar
• Golub, T., Slonim, D., Tamayo, P., et al. (1999) "Molecular classification of cancer: class discovery and class prediction by gene expression monitoring", Science, 286, 531— 537.
   Google Scholar
• Radich, J. (2002) "The promise of gene expression analysis in hematopoetic malignancies", Biochim. Biophy. Acta, 1602, 88–95.
   Google Scholar